Chikungunya Virus Research Tools
App Note / Case Study
Published: August 19, 2025
Brought to you by
Sino Biological
Sino Biological, an international reagent supplier and service provider, specializes in recombinant protein production and antibody development. All of the products are independently developed and produced, including recombinant proteins, antibodies and cDNA. Sino Biological is the researchers' one-stop technical services shop for the advanced technology platforms they need to make advancements and offers pre-clinical production technology services for monoclonal antibody drug candidates.
Credit: Sino Biological
CHIKV has been reported in 119 countries and regions, and there is a potential for widespread outbreak. On July 22, the WHO issued an alert on potential large-scale outbreaks of chikungunya, reminding countries to prepare for solutions to avoid large-scale outbreak.
In response to the new CHIKV (UVE/CHIKV/2024/RE/CNR_79903) variants, Sino Biological quickly launched recombinant E1 and E2 proteins, as well as antibodies, to support researchers in the development of vaccines, antiviral drugs, and immunodiagnostic assays.
In response to the new CHIKV (UVE/CHIKV/2024/RE/CNR_79903) variants, Sino Biological quickly launched recombinant E1 and E2 proteins, as well as antibodies, to support researchers in the development of vaccines, antiviral drugs, and immunodiagnostic assays.
Advertisement